Katasia Cahn
About Katasia Cahn
Katasia Cahn is a Senior Clinical Research Coordinator at Velocity Clinical Research, Inc., where she manages clinical trials and ensures compliance with study protocols. With a background in nursing and psychology, she has developed processes to enhance efficiency in clinical research operations.
Work at Velocity Clinical Research
Katasia Cahn currently serves as a Senior Clinical Research Coordinator at Velocity Clinical Research, Inc. in Lincoln, Nebraska. She has held this position since 2024, managing multiple clinical trials while ensuring compliance with study protocols, ICH GCPs, and IRB reporting requirements. In her role, she has developed new site processes that enhanced employee efficiency and effectiveness in clinical research operations. Cahn also expanded business relations to improve competitiveness in site selection and broaden research capabilities.
Previous Experience in Clinical Research
Before her current role, Katasia Cahn worked as a Clinical Research Coordinator II at Velocity Clinical Research, Inc. from 2021 to 2024. During this time, she contributed to various clinical trials and played a key role in ensuring compliance with regulatory standards. Additionally, she served as a Medical Research Assistant at Celerion from 2018 to 2022, where she supported research activities. Her earlier experience includes working as a Certified Nursing Assistant at Saint Elizabeths Hospital from 2016 to 2017.
Education and Expertise
Katasia Cahn is pursuing a Bachelor of Science in Psychology at Bellevue University, with an expected graduation date in 2025. She has also completed coursework towards a Bachelor of Nursing at both Southeast Community College and the University of Nebraska-Lincoln, from 2016 to 2021. This educational background provides her with a solid foundation in both psychological principles and nursing practices, enhancing her capabilities in clinical research.
Clinical Research Contributions
In her professional capacity, Katasia Cahn has ensured the timely and accurate completion of feasibility questionnaires, vendor agreements, and regulatory documents from study start-up to site initiation. She has served as the primary contact for establishing strong relationships with Sponsors, Clinical Research Associates (CRAs), and Principal Investigators, which is essential for the success of clinical trials.